โณ Fetching live dividend data...
Home โบ Calculator โบ BRKR Dividend Calculator 2026
Bruker Corporation ยท NASDAQ
Price: $59.41 ยท Annual div: $0.20/share ยท Frequency: quarterly ยท Payout ratio: 50% ยท Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BRKR โ $2.66M in 10 years ยท $1.47/month
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. ยท Privacy Policy
Ready to invest? Open BRKR position with:
Real after-tax yield depends on where you live and how you hold BRKR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| ๐บ๐ธ Roth IRA / 401k | 0% | 0.34% | -2.46% | $34 / yr |
| ๐บ๐ธ US Taxable (15%) โ | 15% | 0.29% | -2.51% | $29 / yr |
| ๐บ๐ธ US Taxable (20%) | 20% | 0.27% | -2.53% | $27 / yr |
| ๐ฌ๐ง UK ISA | 0% | 0.34% | -2.46% | $34 / yr |
| ๐ฌ๐ง UK Taxable | 8.75% | 0.31% | -2.49% | $31 / yr |
| ๐จ๐ฆ TFSA | 0% | 0.34% | -2.46% | $34 / yr |
| ๐จ๐ฆ CA Taxable | 25% | 0.26% | -2.54% | $26 / yr |
| ๐ฆ๐บ Super (pension) | 15% | 0.29% | -2.51% | $29 / yr |
| ๐ฆ๐บ AU Taxable | 30% | 0.24% | -2.56% | $24 / yr |
| ๐ฉ๐ช DE Taxable | 26.375% | 0.25% | -2.55% | $25 / yr |
| ๐ซ๐ท FR Taxable | 30% | 0.24% | -2.56% | $24 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.20/share/yr ยท ๐บ๐ธ US Taxable (15%) ยท static projection (no growth assumed).
BRKR pays quarterly โ 4 times per year. Next ex-div: TBD.
How BRKR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024โ2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BRKR sourced from FMP /financial-growth endpoint โ real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-08-15 | 3,303 | โ | โ | ||
| A-Award | 2026-08-15 | 2,678 | $57.70 | $154.5K | ||
| A-Award | 2026-08-15 | 3,120 | โ | โ | ||
| Sale | 2026-08-17 | 3,473 | $56.90 | $197.6K | ||
| A-Award | 2026-08-15 | 2,529 | $57.70 | $145.9K | ||
| A-Award | 2026-08-15 | 4,035 | โ | โ | ||
| A-Award | 2026-08-15 | 16,898 | โ | โ | ||
| A-Award | 2026-08-15 | 13,698 | $57.70 | $790.4K | ||
| A-Award | 2026-08-15 | 29,463 | โ | โ | ||
| F-InKind | 2026-08-15 | 4,760 | $57.70 | $274.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores โ lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BRKR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer โ
Bruker Corporation (BRKR) is currently trading at $59.41, 36% below its 52-week high. The current dividend yield is 0.34% based on an annual payout of $0.20 per share.
Bruker Corporation (BRKR) is a healthcare stock currently trading at $59.41 with a dividend yield of 0.34%. The company pays an annual dividend of $0.20 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, BRKR has grown its dividend at a compound annual rate of 6.3%.
Auto-generated from live market data. For educational purposes only โ not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
โFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.โ
โI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly โ $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.โ
โReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.โ
โAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.โ
โThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.โ
Reviews reflect users' personal experiences. Not financial advice.
Leave a review โIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
โฑ๏ธ Takes 30 seconds ยท No signup ยท Free forever